Anika Therapeutics, Inc. (ANIK)
21.31
-0.47
(-2.16%)
USD |
NASDAQ |
Aug 24, 16:00
21.31
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics Total Assets (Quarterly) : 183.47M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 183.47M |
| March 31, 2026 | 179.39M |
| December 31, 2025 | 202.44M |
| September 30, 2025 | 189.44M |
| June 30, 2025 | 187.68M |
| March 31, 2025 | 190.60M |
| December 31, 2024 | 215.63M |
| September 30, 2024 | 231.40M |
| June 30, 2024 | 262.66M |
| March 31, 2024 | 263.74M |
| December 31, 2023 | 285.45M |
| September 30, 2023 | 328.16M |
| June 30, 2023 | 328.88M |
| March 31, 2023 | 339.07M |
| December 31, 2022 | 349.13M |
| September 30, 2022 | 347.75M |
| June 30, 2022 | 354.12M |
| March 31, 2022 | 342.24M |
| December 31, 2021 | 365.31M |
| September 30, 2021 | 352.93M |
| June 30, 2021 | 363.13M |
| March 31, 2021 | 362.25M |
| December 31, 2020 | 381.29M |
| September 30, 2020 | 416.34M |
| June 30, 2020 | 440.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 398.91M |
| December 31, 2019 | 342.24M |
| September 30, 2019 | 319.58M |
| June 30, 2019 | 287.36M |
| March 31, 2019 | 306.66M |
| December 31, 2018 | 286.20M |
| September 30, 2018 | 269.26M |
| June 30, 2018 | 265.41M |
| March 31, 2018 | 284.34M |
| December 31, 2017 | 287.39M |
| September 30, 2017 | 273.13M |
| June 30, 2017 | 265.00M |
| March 31, 2017 | 247.37M |
| December 31, 2016 | 240.25M |
| September 30, 2016 | 231.06M |
| June 30, 2016 | 222.74M |
| March 31, 2016 | 214.46M |
| December 31, 2015 | 235.75M |
| September 30, 2015 | 222.85M |
| June 30, 2015 | 208.01M |
| March 31, 2015 | 197.68M |
| December 31, 2014 | 194.00M |
| September 30, 2014 | 185.50M |
| June 30, 2014 | 179.10M |
| March 31, 2014 | 174.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 392.02M |
| MiMedx Group, Inc. | 281.00M |
| ABVC BioPharma, Inc. | 19.40M |
| Enovis Corp. | 3.766B |
| Edwards Lifesciences Corp. | 13.87B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.19M |
| Shareholders Equity (Quarterly) | 137.28M |
| Debt to Equity Ratio | 0.1839 |
| Current Ratio | 4.479 |
| Net Debt Paydown Yield | 0.02% |